Clinical Trial Update: Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD) [Phase 1]

View source ↗

Summary

Phase 1 study assessing acute effects of medium-chain triglyceride–induced nutritional ketosis on symptoms and biomarkers in Parkinson's disease; completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED | Results posted: 2022-08-12